The global Biosimilar Monoclonal Antibodies market was valued at 4770.99 Million USD in 2020 and will grow with a CAGR of 28.25% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.The classification of Biosimilar Monoclonal Antibodies includes Infliximab, Rituximab, Trastuzumab, Adalimumab and Other, and the sales proportion of Infliximab in 2017 is about 36.5%.
By Market Verdors:
Celltrion
Pfizer (Hospira)
3SBIO
Novartis (Sandoz)
Dr Reddy`s
Celgen Biopharma
Cadila Healthcare
Hisun Pharma
Torrent Pharmaceuticals
By Types:
Infliximab
Rituximab
Trastuzumab
Adalimumab
By Applications:
Oncology
Autoimmune Disease
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
2021-2027 Global and Regional Biosimilar Monoclonal Antibodies Industry Status and Prospects Professional Market Research Report Standard Version
Table of Contents
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Biosimilar Monoclonal Antibodies Market Size Analysis from 2022 to 2027
1.5.1 Global Biosimilar Monoclonal Antibodies Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Biosimilar Monoclonal Antibodies Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Biosimilar Monoclonal Antibodies Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Biosimilar Monoclonal Antibodies Industry Impact
Chapter 2 Global Biosimilar Monoclonal Antibodies Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biosimilar Monoclonal Antibodies (Volume and Value) by Type
2.1.1 Global Biosimilar Monoclonal Antibodies Consumption and Market Share by Type (2016-2021)
2.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2016-2021)
2.2 Global Biosimilar Monoclonal Antibodies (Volume and Value) by Application
2.2.1 Global Biosimilar Monoclonal Antibodies Consumption and Market Share by Application (2016-2021)
2.2.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Application (2016-2021)
2.3 Global Biosimilar Monoclonal Antibodies (Volume and Value) by Regions
2.3.1 Global Biosimilar Monoclonal Antibodies Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Biosimilar Monoclonal Antibodies Consumption by Regions (2016-2021)
4.2 North America Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
4.10 South America Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Biosimilar Monoclonal Antibodies Market Analysis
5.1 North America Biosimilar Monoclonal Antibodies Consumption and Value Analysis
5.1.1 North America Biosimilar Monoclonal Antibodies Market Under COVID-19
5.2 North America Biosimilar Monoclonal Antibodies Consumption Volume by Types
5.3 North America Biosimilar Monoclonal Antibodies Consumption Structure by Application
5.4 North America Biosimilar Monoclonal Antibodies Consumption by Top Countries
5.4.1 United States Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
5.4.2 Canada Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
5.4.3 Mexico Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Chapter 6 East Asia Biosimilar Monoclonal Antibodies Market Analysis
6.1 East Asia Biosimilar Monoclonal Antibodies Consumption and Value Analysis
6.1.1 East Asia Biosimilar Monoclonal Antibodies Market Under COVID-19
6.2 East Asia Biosimilar Monoclonal Antibodies Consumption Volume by Types
6.3 East Asia Biosimilar Monoclonal Antibodies Consumption Structure by Application
6.4 East Asia Biosimilar Monoclonal Antibodies Consumption by Top Countries
6.4.1 China Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
6.4.2 Japan Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
6.4.3 South Korea Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Chapter 7 Europe Biosimilar Monoclonal Antibodies Market Analysis
7.1 Europe Biosimilar Monoclonal Antibodies Consumption and Value Analysis
7.1.1 Europe Biosimilar Monoclonal Antibodies Market Under COVID-19
7.2 Europe Biosimilar Monoclonal Antibodies Consumption Volume by Types
7.3 Europe Biosimilar Monoclonal Antibodies Consumption Structure by Application
7.4 Europe Biosimilar Monoclonal Antibodies Consumption by Top Countries
7.4.1 Germany Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
7.4.2 UK Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
7.4.3 France Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
7.4.4 Italy Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
7.4.5 Russia Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
7.4.6 Spain Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
7.4.7 Netherlands Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
7.4.8 Switzerland Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
7.4.9 Poland Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Chapter 8 South Asia Biosimilar Monoclonal Antibodies Market Analysis
8.1 South Asia Biosimilar Monoclonal Antibodies Consumption and Value Analysis
8.1.1 South Asia Biosimilar Monoclonal Antibodies Market Under COVID-19
8.2 South Asia Biosimilar Monoclonal Antibodies Consumption Volume by Types
8.3 South Asia Biosimilar Monoclonal Antibodies Consumption Structure by Application
8.4 South Asia Biosimilar Monoclonal Antibodies Consumption by Top Countries
8.4.1 India Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
8.4.2 Pakistan Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Biosimilar Monoclonal Antibodies Market Analysis
9.1 Southeast Asia Biosimilar Monoclonal Antibodies Consumption and Value Analysis
9.1.1 Southeast Asia Biosimilar Monoclonal Antibodies Market Under COVID-19
9.2 Southeast Asia Biosimilar Monoclonal Antibodies Consumption Volume by Types
9.3 Southeast Asia Biosimilar Monoclonal Antibodies Consumption Structure by Application
9.4 Southeast Asia Biosimilar Monoclonal Antibodies Consumption by Top Countries
9.4.1 Indonesia Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
9.4.2 Thailand Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
9.4.3 Singapore Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
9.4.4 Malaysia Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
9.4.5 Philippines Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
9.4.6 Vietnam Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
9.4.7 Myanmar Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Chapter 10 Middle East Biosimilar Monoclonal Antibodies Market Analysis
10.1 Middle East Biosimilar Monoclonal Antibodies Consumption and Value Analysis
10.1.1 Middle East Biosimilar Monoclonal Antibodies Market Under COVID-19
10.2 Middle East Biosimilar Monoclonal Antibodies Consumption Volume by Types
10.3 Middle East Biosimilar Monoclonal Antibodies Consumption Structure by Application
10.4 Middle East Biosimilar Monoclonal Antibodies Consumption by Top Countries
10.4.1 Turkey Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
10.4.3 Iran Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
10.4.5 Israel Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
10.4.6 Iraq Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
10.4.7 Qatar Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
10.4.8 Kuwait Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
10.4.9 Oman Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Chapter 11 Africa Biosimilar Monoclonal Antibodies Market Analysis
11.1 Africa Biosimilar Monoclonal Antibodies Consumption and Value Analysis
11.1.1 Africa Biosimilar Monoclonal Antibodies Market Under COVID-19
11.2 Africa Biosimilar Monoclonal Antibodies Consumption Volume by Types
11.3 Africa Biosimilar Monoclonal Antibodies Consumption Structure by Application
11.4 Africa Biosimilar Monoclonal Antibodies Consumption by Top Countries
11.4.1 Nigeria Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
11.4.2 South Africa Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
11.4.3 Egypt Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
11.4.4 Algeria Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
11.4.5 Morocco Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Chapter 12 Oceania Biosimilar Monoclonal Antibodies Market Analysis
12.1 Oceania Biosimilar Monoclonal Antibodies Consumption and Value Analysis
12.2 Oceania Biosimilar Monoclonal Antibodies Consumption Volume by Types
12.3 Oceania Biosimilar Monoclonal Antibodies Consumption Structure by Application
12.4 Oceania Biosimilar Monoclonal Antibodies Consumption by Top Countries
12.4.1 Australia Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
12.4.2 New Zealand Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Chapter 13 South America Biosimilar Monoclonal Antibodies Market Analysis
13.1 South America Biosimilar Monoclonal Antibodies Consumption and Value Analysis
13.1.1 South America Biosimilar Monoclonal Antibodies Market Under COVID-19
13.2 South America Biosimilar Monoclonal Antibodies Consumption Volume by Types
13.3 South America Biosimilar Monoclonal Antibodies Consumption Structure by Application
13.4 South America Biosimilar Monoclonal Antibodies Consumption Volume by Major Countries
13.4.1 Brazil Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
13.4.2 Argentina Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
13.4.3 Columbia Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
13.4.4 Chile Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
13.4.5 Venezuela Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
13.4.6 Peru Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
13.4.8 Ecuador Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Biosimilar Monoclonal Antibodies Business
14.1 Celltrion
14.1.1 Celltrion Company Profile
14.1.2 Celltrion Biosimilar Monoclonal Antibodies Product Specification
14.1.3 Celltrion Biosimilar Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Pfizer (Hospira)
14.2.1 Pfizer (Hospira) Company Profile
14.2.2 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Specification
14.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 3SBIO
14.3.1 3SBIO Company Profile
14.3.2 3SBIO Biosimilar Monoclonal Antibodies Product Specification
14.3.3 3SBIO Biosimilar Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Novartis (Sandoz)
14.4.1 Novartis (Sandoz) Company Profile
14.4.2 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Specification
14.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Dr Reddy`s
14.5.1 Dr Reddy`s Company Profile
14.5.2 Dr Reddy`s Biosimilar Monoclonal Antibodies Product Specification
14.5.3 Dr Reddy`s Biosimilar Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Celgen Biopharma
14.6.1 Celgen Biopharma Company Profile
14.6.2 Celgen Biopharma Biosimilar Monoclonal Antibodies Product Specification
14.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Cadila Healthcare
14.7.1 Cadila Healthcare Company Profile
14.7.2 Cadila Healthcare Biosimilar Monoclonal Antibodies Product Specification
14.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Hisun Pharma
14.8.1 Hisun Pharma Company Profile
14.8.2 Hisun Pharma Biosimilar Monoclonal Antibodies Product Specification
14.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Torrent Pharmaceuticals
14.9.1 Torrent Pharmaceuticals Company Profile
14.9.2 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Specification
14.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
15.1 Global Biosimilar Monoclonal Antibodies Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Biosimilar Monoclonal Antibodies Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Biosimilar Monoclonal Antibodies Value and Growth Rate Forecast (2022-2027)
15.2 Global Biosimilar Monoclonal Antibodies Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Biosimilar Monoclonal Antibodies Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Biosimilar Monoclonal Antibodies Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Biosimilar Monoclonal Antibodies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Biosimilar Monoclonal Antibodies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Biosimilar Monoclonal Antibodies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Biosimilar Monoclonal Antibodies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Biosimilar Monoclonal Antibodies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Biosimilar Monoclonal Antibodies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Biosimilar Monoclonal Antibodies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Biosimilar Monoclonal Antibodies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Biosimilar Monoclonal Antibodies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Biosimilar Monoclonal Antibodies Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Biosimilar Monoclonal Antibodies Consumption Forecast by Type (2022-2027)
15.3.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Type (2022-2027)
15.3.3 Global Biosimilar Monoclonal Antibodies Price Forecast by Type (2022-2027)
15.4 Global Biosimilar Monoclonal Antibodies Consumption Volume Forecast by Application (2022-2027)
15.5 Biosimilar Monoclonal Antibodies Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
List of Tables and Figures
Figure Product Picture
Figure North America Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure United States Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Canada Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Mexico Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure East Asia Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure China Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Japan Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure South Korea Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Europe Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Germany Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure UK Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure France Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Italy Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Russia Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Spain Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Netherlands Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Switzerland Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Poland Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure South Asia Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure India Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Pakistan Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Bangladesh Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Indonesia Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Thailand Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Singapore Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Malaysia Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Philippines Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Vietnam Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Myanmar Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Middle East Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Turkey Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Saudi Arabia Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Iran Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure United Arab Emirates Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Israel Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Iraq Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Qatar Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Kuwait Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Oman Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Africa Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Nigeria Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure South Africa Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Egypt Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Algeria Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Algeria Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Oceania Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Australia Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure New Zealand Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure South America Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Brazil Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Argentina Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Columbia Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Chile Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Venezuela Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Peru Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Puerto Rico Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Ecuador Biosimilar Monoclonal Antibodies Revenue ($) and Growth Rate (2022-2027)
Figure Global Biosimilar Monoclonal Antibodies Market Size Analysis from 2022 to 2027 by Consumption Volume
Figure Global Biosimilar Monoclonal Antibodies Market Size Analysis from 2022 to 2027 by Value
Table Global Biosimilar Monoclonal Antibodies Price Trends Analysis from 2022 to 2027
Table Global Biosimilar Monoclonal Antibodies Consumption and Market Share by Type (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Consumption and Market Share by Application (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Application (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Consumption and Market Share by Regions (2016-2021)
Table Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Regions (2016-2021)
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Major Manufacturers Capacity and Total Capacity
Table 2016-2021 Major Manufacturers Capacity Market Share
Table 2016-2021 Major Manufacturers Production and Total Production
Table 2016-2021 Major Manufacturers Production Market Share
Table 2016-2021 Major Manufacturers Revenue and Total Revenue
Table 2016-2021 Major Manufacturers Revenue Market Share
Table 2016-2021 Regional Market Capacity and Market Share
Table 2016-2021 Regional Market Production and Market Share
Table 2016-2021 Regional Market Revenue and Market Share
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table 2016-2021 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2016-2021 Capacity, Production and Growth Rate
Figure 2016-2021 Revenue, Gross Margin and Growth Rate
Table Global Biosimilar Monoclonal Antibodies Consumption by Regions (2016-2021)
Figure Global Biosimilar Monoclonal Antibodies Consumption Share by Regions (2016-2021)
Table North America Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
Table East Asia Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
Table Europe Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
Table South Asia Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
Table Southeast Asia Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
Table Middle East Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
Table Africa Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
Table Oceania Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
Table South America Biosimilar Monoclonal Antibodies Sales, Consumption, Export, Import (2016-2021)
Figure North America Biosimilar Monoclonal Antibodies Consumption and Growth Rate (2016-2021)
Figure North America Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2016-2021)
Table North America Biosimilar Monoclonal Antibodies Sales Price Analysis (2016-2021)
Table North America Biosimilar Monoclonal Antibodies Consumption Volume by Types
Table North America Biosimilar Monoclonal Antibodies Consumption Structure by Application
Table North America Biosimilar Monoclonal Antibodies Consumption by Top Countries
Figure United States Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Canada Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Mexico Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure East Asia Biosimilar Monoclonal Antibodies Consumption and Growth Rate (2016-2021)
Figure East Asia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2016-2021)
Table East Asia Biosimilar Monoclonal Antibodies Sales Price Analysis (2016-2021)
Table East Asia Biosimilar Monoclonal Antibodies Consumption Volume by Types
Table East Asia Biosimilar Monoclonal Antibodies Consumption Structure by Application
Table East Asia Biosimilar Monoclonal Antibodies Consumption by Top Countries
Figure China Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Japan Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure South Korea Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Europe Biosimilar Monoclonal Antibodies Consumption and Growth Rate (2016-2021)
Figure Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2016-2021)
Table Europe Biosimilar Monoclonal Antibodies Sales Price Analysis (2016-2021)
Table Europe Biosimilar Monoclonal Antibodies Consumption Volume by Types
Table Europe Biosimilar Monoclonal Antibodies Consumption Structure by Application
Table Europe Biosimilar Monoclonal Antibodies Consumption by Top Countries
Figure Germany Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure UK Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure France Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Italy Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Russia Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Spain Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Netherlands Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Switzerland Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Poland Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure South Asia Biosimilar Monoclonal Antibodies Consumption and Growth Rate (2016-2021)
Figure South Asia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2016-2021)
Table South Asia Biosimilar Monoclonal Antibodies Sales Price Analysis (2016-2021)
Table South Asia Biosimilar Monoclonal Antibodies Consumption Volume by Types
Table South Asia Biosimilar Monoclonal Antibodies Consumption Structure by Application
Table South Asia Biosimilar Monoclonal Antibodies Consumption by Top Countries
Figure India Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Pakistan Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Bangladesh Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Southeast Asia Biosimilar Monoclonal Antibodies Consumption and Growth Rate (2016-2021)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2016-2021)
Table Southeast Asia Biosimilar Monoclonal Antibodies Sales Price Analysis (2016-2021)
Table Southeast Asia Biosimilar Monoclonal Antibodies Consumption Volume by Types
Table Southeast Asia Biosimilar Monoclonal Antibodies Consumption Structure by Application
Table Southeast Asia Biosimilar Monoclonal Antibodies Consumption by Top Countries
Figure Indonesia Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Thailand Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Singapore Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Malaysia Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Philippines Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Vietnam Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Myanmar Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Middle East Biosimilar Monoclonal Antibodies Consumption and Growth Rate (2016-2021)
Figure Middle East Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2016-2021)
Table Middle East Biosimilar Monoclonal Antibodies Sales Price Analysis (2016-2021)
Table Middle East Biosimilar Monoclonal Antibodies Consumption Volume by Types
Table Middle East Biosimilar Monoclonal Antibodies Consumption Structure by Application
Table Middle East Biosimilar Monoclonal Antibodies Consumption by Top Countries
Figure Turkey Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Saudi Arabia Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Iran Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure United Arab Emirates Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Israel Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Iraq Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Qatar Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Kuwait Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
Figure Oman Biosimilar Monoclonal Antibodies Consumption Volume from 2016 to 2021
F
Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 147
According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period.
The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
Global Biosimilar Drug Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 147
According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
Global Biosimilars Market Research Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 2680 Onwards Pages: 167
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 3280 Onwards Pages: 133
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 07-Dec-2023 Price: US 3380 Onwards Pages: 106
Market Overview of Global Biosimilars market:
According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years.
A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 3280 Onwards Pages: 134
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 2680 Onwards Pages: 160
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 16-Nov-2023 Price: US 3380 Onwards Pages: 103
Market Overview of Global Biosimilar Monoclonal Antibodies market:
According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
